---
title: "Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares worth $303,170"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291978309.md"
description: "Cytokinetics EVP R&D Malik Fady Ibraham exercised options for 3,500 shares at $7.80 and sold them the same day at $86.62 on July 7, 2026. Following the transaction, he holds 153,902 beneficially owned common shares and has 37,386 non-qualified stock options outstanding."
datetime: "2026-07-07T21:07:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291978309.md)
  - [en](https://longbridge.com/en/news/291978309.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291978309.md)
---

# Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares worth $303,170

-   Cytokinetics EVP of Research & Development Malik Fady Ibraham exercised stock options for 3,500 shares on July 7, 2026 at USD 7.8. \* He sold 3,500 shares the same day at USD 86.62. \* He ended the day with 153,902 shares of common stock beneficially owned. \* He also reported 37,386 non-qualified stock options outstanding following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000075), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $575,700](https://longbridge.com/en/news/295452544.md)
- [Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $606,525](https://longbridge.com/en/news/293972048.md)
- [Zalaris publishes minutes from extraordinary general meeting](https://longbridge.com/en/news/295536162.md)
- [AirAsia flights face disruption as heavy rain, thunderstorms hit Kuala Lumpur operations](https://longbridge.com/en/news/295500433.md)
- [Terra Santa updates related-party transactions policy at Aug. 10 board meeting](https://longbridge.com/en/news/295461441.md)